PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-27.41%
Cash & equivalents declining signals potential liquidity drain. Benjamin Graham would investigate if this is from strategic investments or operational shortfalls.
No Data
No Data available this quarter, please select a different quarter.
-27.41%
Declining total liquid assets may signal capital redeployment or liquidity concerns. Howard Marks would investigate the underlying causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.07%
Other current assets up to 5% yoy – slight increase. Howard Marks would confirm if these items remain genuinely short-term.
-28.37%
Declining current assets may signal efficient working capital or liquidity concerns. Benjamin Graham would investigate the composition of the decline.
1187.39%
Net PP&E up ≥ 20% yoy – significant capacity expansion. Benjamin Graham would check if demand justifies the capital spending.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.01%
Up to 5% yoy – slight expansion. Howard Marks would verify the purpose of these new or intangible assets.
252.00%
Non-current assets up ≥ 20% yoy – rapid expansion. Benjamin Graham would verify if these assets can generate sufficient returns.
No Data
No Data available this quarter, please select a different quarter.
-17.83%
Declining total assets may signal asset sales or strategic downsizing. Seth Klarman would investigate the strategic rationale.
-8.53%
Declining payables indicates faster supplier payments but reduces free financing. Howard Marks would verify liquidity remains adequate.
-29.62%
Declining short-term debt reduces immediate leverage risk. Benjamin Graham would see this as improving financial safety.
No Data
No Data available this quarter, please select a different quarter.
12.29%
Growth 10-20% – healthy pipeline. Benjamin Graham checks that delivery costs won't erode margins.
No Data
No Data available this quarter, please select a different quarter.
-3.44%
Declining current liabilities reduces short-term financial pressure. Seth Klarman would see this as improving liquidity position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7668.72%
Above 5% yoy – rising long-term liabilities. Philip Fisher wants clarity on new debts or deferrals.
No Data
No Data available this quarter, please select a different quarter.
13.42%
Above 10% yoy – large jump. Philip Fisher demands clarity on whether growth justifies the leverage.
2.97%
Up to 5% yoy – small issuance. Howard Marks asks if new capital is used productively.
-3.03%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
25.83%
Above 20% yoy – large jump. Philip Fisher demands clarity on whether these unrealized gains are sustainable.
No Data
No Data available this quarter, please select a different quarter.
-39.38%
Declining stockholders equity may signal losses or large distributions. Seth Klarman would investigate the underlying causes and sustainability.
-17.83%
Declining total capital may indicate asset sales or poor capital allocation. Howard Marks would investigate strategic implications.
No Data
No Data available this quarter, please select a different quarter.
499.58%
Above 5% yoy – debt expansion. Philip Fisher demands clarity on whether new debt is productive or just adding leverage.
37.73%
Above 5% yoy – net debt expansion. Philip Fisher demands clarity on the reason for higher leverage vs. cash.